LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Chemical mediators and the resolution of airway inflammation.

Carlo, Troy / Levy, Bruce D

Allergology international : official journal of the Japanese Society of Allergology

2008  Volume 57, Issue 4, Page(s) 299–305

Abstract: ... Some of these counter-regulatory lipid mediators have been identified in the airway during asthma and defects ... inflammation resolution is an active process orchestrated by specific chemical mediators that are elaborated ... of pro-resolving chemical mediators and provide examples of select mediators and their structural analogs ...

Abstract Asthma pathobiology is remarkable for chronic airway inflammation that fails to spontaneously resolve. No curative therapy is currently available. A growing body of evidence indicates that, in health, inflammation resolution is an active process orchestrated by specific chemical mediators that are elaborated to restore tissue homeostasis. Activated cell membranes release polyunsaturated fatty acids from phospholipids for enzymatic conversion to biologically active mediators with profound regulatory effects on innate and adaptive immunity. Some of these mediators carry anti-inflammatory and pro-resolving actions that are transduced in a cell-type specific manner via specific recognition sites that initiate regulatory intracellular signals, such as presqualene diphosphate remodeling, to limit pro-phlogistic cell activation. Some of these counter-regulatory lipid mediators have been identified in the airway during asthma and defects in their production are associated with disease severity. In this review, we describe the biosynthesis and bioactions of pro-resolving chemical mediators and provide examples of select mediators and their structural analogs with particular relevance to asthma.
MeSH term(s) Animals ; Biomimetics/trends ; CD59 Antigens/metabolism ; CD59 Antigens/therapeutic use ; Diet ; Eicosapentaenoic Acid/analogs & derivatives ; Eicosapentaenoic Acid/genetics ; Eicosapentaenoic Acid/metabolism ; Feedback, Physiological ; Fish Oils/metabolism ; Guinea Pigs ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/isolation & purification ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/metabolism ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Lipid Metabolism/immunology ; Lipoxins/genetics ; Lipoxins/metabolism ; Mice ; Polyisoprenyl Phosphates/metabolism ; Polyisoprenyl Phosphates/therapeutic use ; Respiratory Hypersensitivity/diet therapy ; Respiratory Hypersensitivity/drug therapy ; Respiratory Hypersensitivity/immunology ; Respiratory Hypersensitivity/metabolism ; Signal Transduction/immunology
Chemical Substances CD59 Antigens ; Fish Oils ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Lipoxins ; Polyisoprenyl Phosphates ; presqualene pyrophosphate (29849-75-0) ; Eicosapentaenoic Acid (AAN7QOV9EA) ; 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid (GND3JH08JA)
Language English
Publishing date 2008-11-01
Publishing country England
Document type Journal Article ; Review
ZDB-ID 1336498-4
ISSN 1440-1592 ; 1323-8930
ISSN (online) 1440-1592
ISSN 1323-8930
DOI 10.2332/allergolint.08-RAI-0018
Shelf mark
Zs.A 5248: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top